deoxycytidine and Urogenital Neoplasms

deoxycytidine has been researched along with Urogenital Neoplasms in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (12.50)	18.2507
2000's	6 (75.00)	29.6817
2010's	1 (12.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ichioka, D; Inai, H; Kawai, K; Miyazaki, J; Nishiyama, H	1
Culine, S	1
Sternberg, CN; Vogelzang, NJ	1
Friedrich, C; Krege, S; Pientka, L; Rübben, H	1
Inui, K; Ito, N; Jiko, M; Kamoto, T; Masuda, S; Motohashi, H; Nakamura, E; Ogawa, O; Okuda, M; Sato, E; Segawa, T; Takahashi, K; Yano, I	1
Csoka, K; Larsson, R; Liliemark, J; Nygren, P	1
Misset, JL	1
Vogelzang, NJ	1

Reviews

6 review(s) available for deoxycytidine and Urogenital Neoplasms

Article	Year
Assessment and management of renal impairment in chemotherapy for urogenital cancer. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:11 Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Deoxycytidine; Gemcitabine; Glomerular Filtration Rate; Humans; Incidence; Kidney; Male; Renal Insufficiency, Chronic; Survival Rate; Testicular Neoplasms; Urogenital Neoplasms; Urothelium	2013
[Gemcitabine and urogenital tumors]. Bulletin du cancer, 2002, Volume: 89 Spec No Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cystectomy; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Germinoma; Hematologic Diseases; Humans; Kidney Neoplasms; Male; Methotrexate; Organoplatinum Compounds; Patient Selection; Prostatic Neoplasms; Salvage Therapy; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine	2002
Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers. Critical reviews in oncology/hematology, 2003, Jun-27, Volume: 46 Suppl Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Glutamates; Guanine; Humans; Kidney Neoplasms; Paclitaxel; Pemetrexed; Urogenital Neoplasms; Urothelium	2003
[Geriatric urology -- tumour diseases]. Aktuelle Urologie, 2006, Volume: 37, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Deoxycytidine; Female; Gemcitabine; Hematopoietic Cell Growth Factors; Humans; Male; Middle Aged; Patient Care Team; Prostatic Neoplasms; Taxoids; Urinary Bladder Neoplasms; Urogenital Neoplasms	2006
Brief communication: use of the multitargeted antifolate pemetrexed (Alimta) in genitourinary cancer. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Clinical Trials, Phase II as Topic; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Folic Acid Antagonists; Gemcitabine; Glutamates; Guanine; Humans; Irinotecan; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Survival Analysis; Treatment Outcome; Urinary Bladder Neoplasms; Urogenital Neoplasms	2002
Future directions for gemcitabine in the treatment of genitourinary cancer. Seminars in oncology, 2002, Volume: 29, Issue:1 Suppl 3 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Female; Forecasting; Gemcitabine; Humans; Kidney Neoplasms; Male; Morbidity; Prostatic Neoplasms; Survival Analysis; Testicular Neoplasms; Treatment Outcome; United States; Urinary Bladder Neoplasms; Urogenital Neoplasms	2002

Other Studies

2 other study(ies) available for deoxycytidine and Urogenital Neoplasms

Article	Year
Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers. International journal of clinical oncology, 2007, Volume: 12, Issue:4 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deoxycytidine; Gemcitabine; Genotype; Humans; Male; Metabolic Clearance Rate; Middle Aged; Paclitaxel; Polymorphism, Genetic; Prostate-Specific Antigen; Urogenital Neoplasms	2007
Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors. Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms	1995

Article

Year

Pharmacokinetics and pharmacodynamics of paclitaxel with carboplatin or gemcitabine, and effects of CYP3A5 and MDR1 polymorphisms in patients with urogenital cancers.

International journal of clinical oncology, 2007, Volume: 12, Issue:4

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carboplatin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Deoxycytidine; Gemcitabine; Genotype; Humans; Male; Metabolic Clearance Rate; Middle Aged; Paclitaxel; Polymorphism, Genetic; Prostate-Specific Antigen; Urogenital Neoplasms

2007

Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.

Seminars in oncology, 1995, Volume: 22, Issue:4 Suppl 11

Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cladribine; Colorectal Neoplasms; Cytarabine; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Gemcitabine; Humans; In Vitro Techniques; Leukemia; Lung Neoplasms; Lymphoma; Ribonucleotide Reductases; Tumor Cells, Cultured; Urogenital Neoplasms

1995